THE BIOSCIENCES GROUP
Chicago, IL (AMRI Research Site)
THE ONCOLOGY GROUP
Ian L. Scott, Ph.D.
Program yielded a novel vinca derivative, ALB-109564(a), which has completed phase I clinical trials.
Responsible for all start-up activities of new group including setting criteria for project selection and identifying suitable programs
Managed medicinal chemistry optimization effort of lead molecules
Author and principal inventor on 3 issued US patents
Dr. Scott established The Oncology group as part of an initiative to create internal research programs.
A major goal of this team was to leverage the company’s strengths in natural products and bio-catalysis
The Biosciences Group was focused on the use of enzymes and microbes for organic synthesis (28 staff members). Dr. Scott's mandate as Head of this division closely paralleled that for the Bothell Research Center. He evaluated ongoing research programs, teams and scientific approaches, and implemented changes to maximize the potential of the division.